Article may be outdated

This article is 9 days old. Some details may have changed since publication.

Headlinne
Sign inGet Headlinne
Inside Precision Medicine·3 min read·hard

FDA Approves First mRNA Flu Vaccine

H
Helen Albert
FDA Approves First mRNA Flu Vaccine
✦AI Summary

The FDA has approved Moderna's mFlusiva, the first mRNA-based influenza vaccine for adults aged 50 and older. This approval marks a significant milestone for mRNA technology beyond COVID-19 applications.

Why it mattersUnlock →

The FDA has approved Moderna’s influenza vaccine, mFlusiva, for use in adults aged 50 years and older after positive Phase III results in a trial of more than 40,000 people in this age group.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthsciencetechnology
Political bias analysisUnlock →
Read originalGet full access
✦

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in